Catalyst Wire Dossier Catalyst Wire Dossier

Razuprotafib

razuprotafib · EyePoint Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Razuprotafib, covering 2023-06-08 to 2023-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019 [Phase 2]

See pricing